Yurut-Caloglu, VuslatCaloglu, MuratTokatli, FusunKocak, ZaferCosar-Alas, RusenIbis, KamuranKaragol, Hakan2024-06-122024-06-1220061300-7467https://hdl.handle.net/20.500.14551/22285Malignant melanoma is a skin cancer with poor prognosis. Historically melanoma has been thought of as a relatively radioresistant tumour. Nowadays, radiation delivered according to hypofractionated schedule is the most used, although there are few data confirm that this schedule improves the therapeutic impact. We report a case, with stage IV malignant melanoma, whose tumoral bleeding was palliated successfully giving 20 Gy external radiotherapy in 5 fractionations.trinfo:eu-repo/semantics/closedAccessMalignant MelanomaMelanoma/Pathology/RadiotherapyNeoplasms, Multiple Primary/Pathology/RadiotherapyArticle213151155N/AWOS:000439249000007